Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Nov 11, 2021 5:18pm
103 Views
Post# 34117089

RE:Good old fashioned warrants

RE:Good old fashioned warrantsMuch depends upon the terms of the warrants and the need for cash. If the warrants are priced to convert at too high a price, it will not bring in the desired cash in a rapid time frame. If they were priced attractively, however, it would be one way to make it up to legacy shareholders for the disaster of the ONO and could raise some additional cash for TH. In other words, if TH needs cash now and wants to make amends with shareholders, list the warrants at a strike price that is in the money right away and legacy shareholders could convert their warrants at the attractive price and provide the company with cash or sell the warrants to someone else who would convert them and provide the needed cash. So, it is an idea with some merit if TH wants to heal some old wounds and get some cash. 

Scioto1 wrote:
Have a question for our esteemed brain trust. An instrument used, fairly regularly, when I 1st started investing is stock warrants. What does the brain trust think about advancing the idea of thtx issuing warrants that would be listed on the market to existing stock holders, at a reasonable strike price as opposed to private solicitations or shelf offering? This would allow those who've been invested for a while to either take advantage of the warrants to buy more or sell them on the market -- a way to reward long term investors and raise money at the desired price. Thoughts?


<< Previous
Bullboard Posts
Next >>